Authors:
ACHARI R
HOSMANE B
LINNEN P
CAVANAUGH J
BAROLDI P
COHEN A
Citation: R. Achari et al., EFFECTS OF ORAL AND INTRAVENOUS TERAZOSIN AND HEAD-UP TILT ON BLOOD-PRESSURE RESPONSES IN PATIENTS WITH HYPERTENSION, Journal of clinical pharmacology, 38(6), 1998, pp. 545-553
Citation: Sd. Collins et al., DEPAKOTE CR - BIOPHARMACEUTICAL AND PHARMACOKINETIC STUDIES OF A NEW FORMULATION FOR ONCE-DAILY DOSING, Neurology, 50(4), 1998, pp. 64004-64004
Authors:
OUELLET D
HSU A
GRANNEMAN GR
CARLSON G
CAVANAUGH J
GUENTHER H
LEONARD JM
Citation: D. Ouellet et al., PHARMACOKINETIC INTERACTION BETWEEN RITONAVIR AND CLARITHROMYCIN, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 355-362
Authors:
CATO A
CAVANAUGH J
SHI H
HSU A
LEONARD J
GRANNEMAN R
Citation: A. Cato et al., THE EFFECT OF MULTIPLE DOSES OF RITONAVIR ON THE PHARMACOKINETICS OF RIFABUTIN, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 414-421
Citation: J. Cavanaugh, PLASTIC TANKS OFFER SOLUTIONS FOR ABOVEGROUND STORAGE - DESIGN IMPROVEMENTS MAKE THERMOPLASTICS A VIABLE ALTERNATIVE TO METALS AND FIBERGLASS, Chemical processing, 61(8), 1998, pp. 85
Authors:
ILLIG KA
SCHMIDT E
CAVANAUGH J
KRUSCH D
SAX HC
Citation: Ka. Illig et al., ARE PROPHYLACTIC ANTIBIOTICS REQUIRED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY, Journal of the American College of Surgeons, 184(4), 1997, pp. 353-356
Authors:
CATO A
CAO GL
HSU A
CAVANAUGH J
LEONARD J
GRANNEMAN R
Citation: A. Cato et al., EVALUATION OF THE EFFECT OF FLUCONAZOLE ON THE PHARMACOKINETICS OF RITONAVIR, Drug metabolism and disposition, 25(9), 1997, pp. 1104-1106
Authors:
CAVANAUGH J
WILSON S
SRAML M
STANFORD P
GORSKA M
FOOTE S
CALLEN D
PAVLI P
Citation: J. Cavanaugh et al., AFFECTED SIB-PAIR ANALYSIS OF PERICENTRIC CHROMOSOME-16 MARKERS IN INFLAMMATORY BOWEL-DISEASE FAMILIES, Gastroenterology, 112(4), 1997, pp. 946-946
Authors:
LUDERER J
PIERGIES AA
JORKASKY D
SEDMAN A
REELE S
FROEHLICH J
CAVANAUGH J
STEINMAN GL
Citation: J. Luderer et al., CLINICAL-PHARMACOLOGY AND FIRST-TIME-IN-MAN STUDIES - THE FDA LEVELS THE PLAYING FIELD, Journal of clinical pharmacology, 36(3), 1996, pp. 187-188
Authors:
SAMARA EE
HOSMANE B
LOCKE C
EASON C
CAVANAUGH J
GRANNEMAN GR
Citation: Ee. Samara et al., ASSESSMENT OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEENTERAZOSIN AND FINASTERIDE, Journal of clinical pharmacology, 36(12), 1996, pp. 1169-1178
Authors:
CAVANAUGH J
WILSON S
KOHONENCORISH M
PAVLI P
Citation: J. Cavanaugh et al., AFFECTED SIB PAIR ANALYSIS OF IL1 RECEPTOR ANTAGONIST IN INFLAMMATORYBOWEL-DISEASE FAMILIES, Gastroenterology, 110(4), 1996, pp. 880-880
Authors:
ILLIG KA
SCHMIDT E
CAVANAUGH J
KRUSCH D
SAX HC
Citation: Ka. Illig et al., ARE PROPHYLACTIC ANTIBIOTICS REQUIRED FOR ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY, Gastroenterology, 110(4), 1996, pp. 1394-1394
Authors:
WONG SL
CAVANAUGH J
SHI H
AWNI WM
GRANNEMAN GR
Citation: Sl. Wong et al., EFFECTS OF DIVALPROEX SODIUM ON AMITRIPTYLINE AND NORTRIPTYLINE PHARMACOKINETICS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 48-53
Authors:
CAVANAUGH J
SAMARA E
EASON C
ACHARI R
HOSMANE B
SCHNECK D
Citation: J. Cavanaugh et al., LACK OF ADVERSE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN TERAZOSIN AND FINASTERIDE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 171-171
Citation: S. Chandra et al., ELIMINATION OF NONLIPID ENVELOPED VIRUSES IN THE PREPARATION OF A MONOCLONAL-ANTIBODY PURIFIED AND PASTEURIZED FACTOR-VIII CONCENTRATE (MONOCLATE-P(R)), Blood, 86(10), 1995, pp. 768-768
Authors:
CAVANAUGH J
SCHNECK D
EASON C
HANSEN M
GUSTAVSON L
Citation: J. Cavanaugh et al., LACK OF EFFECT OF FLUOXETINE ON THE PHARMACOKINETICS (PK) PHARMACODYNAMICS (PD) OF ESTAZOLAM, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 141-141